346 related articles for article (PubMed ID: 18174202)
1. Analysis of in vitro activities and modes of action of synthetic antimicrobial peptides derived from an alpha-helical 'sequence template'.
Pag U; Oedenkoven M; Sass V; Shai Y; Shamova O; Antcheva N; Tossi A; Sahl HG
J Antimicrob Chemother; 2008 Feb; 61(2):341-52. PubMed ID: 18174202
[TBL] [Abstract][Full Text] [Related]
2. Synthetic cationic amphiphilic α-helical peptides as antimicrobial agents.
Wiradharma N; Khoe U; Hauser CA; Seow SV; Zhang S; Yang YY
Biomaterials; 2011 Mar; 32(8):2204-12. PubMed ID: 21168911
[TBL] [Abstract][Full Text] [Related]
3. Coupling molecular dynamics simulations with experiments for the rational design of indolicidin-analogous antimicrobial peptides.
Tsai CW; Hsu NY; Wang CH; Lu CY; Chang Y; Tsai HH; Ruaan RC
J Mol Biol; 2009 Sep; 392(3):837-54. PubMed ID: 19576903
[TBL] [Abstract][Full Text] [Related]
4. Synthetic peptides derived from human antimicrobial peptide ubiquicidin accumulate at sites of infections and eradicate (multi-drug resistant) Staphylococcus aureus in mice.
Brouwer CP; Bogaards SJ; Wulferink M; Velders MP; Welling MM
Peptides; 2006 Nov; 27(11):2585-91. PubMed ID: 16814900
[TBL] [Abstract][Full Text] [Related]
5. High potency and broad-spectrum antimicrobial peptides synthesized via ring-opening polymerization of alpha-aminoacid-N-carboxyanhydrides.
Zhou C; Qi X; Li P; Chen WN; Mouad L; Chang MW; Leong SS; Chan-Park MB
Biomacromolecules; 2010 Jan; 11(1):60-7. PubMed ID: 19957992
[TBL] [Abstract][Full Text] [Related]
6. Design and analysis of structure-activity relationship of novel antimicrobial peptides derived from the conserved sequence of cecropin.
Hao G; Shi YH; Han JH; Li QH; Tang YL; Le GW
J Pept Sci; 2008 Mar; 14(3):290-8. PubMed ID: 17929330
[TBL] [Abstract][Full Text] [Related]
7. The antimicrobial peptide hepcidin exerts an important role in the innate immunity against bacteria in the bony fish gilthead seabream.
Cuesta A; Meseguer J; Esteban MA
Mol Immunol; 2008 Apr; 45(8):2333-42. PubMed ID: 18164062
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relations of parasin I, a histone H2A-derived antimicrobial peptide.
Koo YS; Kim JM; Park IY; Yu BJ; Jang SA; Kim KS; Park CB; Cho JH; Kim SC
Peptides; 2008 Jul; 29(7):1102-8. PubMed ID: 18406495
[TBL] [Abstract][Full Text] [Related]
9. Mode of action of human beta-defensin 3 against Staphylococcus aureus and transcriptional analysis of responses to defensin challenge.
Sass V; Pag U; Tossi A; Bierbaum G; Sahl HG
Int J Med Microbiol; 2008 Oct; 298(7-8):619-33. PubMed ID: 18455476
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.
Chou HT; Kuo TY; Chiang JC; Pei MJ; Yang WT; Yu HC; Lin SB; Chen WJ
Int J Antimicrob Agents; 2008 Aug; 32(2):130-8. PubMed ID: 18586467
[TBL] [Abstract][Full Text] [Related]
11. Amphipathic, alpha-helical antimicrobial peptides.
Tossi A; Sandri L; Giangaspero A
Biopolymers; 2000; 55(1):4-30. PubMed ID: 10931439
[TBL] [Abstract][Full Text] [Related]
12. Mammalian defensins: structures and mechanism of antibiotic activity.
Sahl HG; Pag U; Bonness S; Wagner S; Antcheva N; Tossi A
J Leukoc Biol; 2005 Apr; 77(4):466-75. PubMed ID: 15582982
[TBL] [Abstract][Full Text] [Related]
13. Designed low amphipathic peptides with alpha-helical propensity exhibiting antimicrobial activity via a lipid domain formation mechanism.
Yamamoto N; Tamura A
Peptides; 2010 May; 31(5):794-805. PubMed ID: 20109510
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial peptides: new candidates in the fight against bacterial infections.
Toke O
Biopolymers; 2005; 80(6):717-35. PubMed ID: 15880793
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of novel antimicrobial peptides on the basis of alpha helical domain of Tenecin 1, an insect defensin protein, and structure-activity relationship study.
Ahn HS; Cho W; Kang SH; Ko SS; Park MS; Cho H; Lee KH
Peptides; 2006 Apr; 27(4):640-8. PubMed ID: 16226345
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity and mode of action of diastereomeric antimicrobial peptides against bacterial clinical isolates.
Pag U; Oedenkoven M; Papo N; Oren Z; Shai Y; Sahl HG
J Antimicrob Chemother; 2004 Feb; 53(2):230-9. PubMed ID: 14729742
[TBL] [Abstract][Full Text] [Related]
17. Advances in antimicrobial peptide immunobiology.
Yount NY; Bayer AS; Xiong YQ; Yeaman MR
Biopolymers; 2006; 84(5):435-58. PubMed ID: 16736494
[TBL] [Abstract][Full Text] [Related]
18. Strategies for transformation of naturally-occurring amphibian antimicrobial peptides into therapeutically valuable anti-infective agents.
Conlon JM; Al-Ghaferi N; Abraham B; Leprince J
Methods; 2007 Aug; 42(4):349-57. PubMed ID: 17560323
[TBL] [Abstract][Full Text] [Related]
19. Resistance against antimicrobial peptides is independent of Escherichia coli AcrAB, Pseudomonas aeruginosa MexAB and Staphylococcus aureus NorA efflux pumps.
Rieg S; Huth A; Kalbacher H; Kern WV
Int J Antimicrob Agents; 2009 Feb; 33(2):174-6. PubMed ID: 18945595
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial peptides: premises and promises.
Reddy KV; Yedery RD; Aranha C
Int J Antimicrob Agents; 2004 Dec; 24(6):536-47. PubMed ID: 15555874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
